Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

728
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
728
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Cancer Therapies02:49

Cancer Therapies

9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute degron-mediated RUNX1 loss reprograms enhancer activity to epigenetically drive epithelial destabilization and initiate cancer hallmarks.

bioRxiv : the preprint server for biology·2026
Same author

The Crosstalk Between B Cells and the Skeletal System During Development, Aging, and in Pathological Conditions.

Current osteoporosis reports·2025
Same author

RING-Box E3 Ligase Target N-Terminal Lysine 55 to Regulate Turnover of Sp7 Protein.

Journal of cellular biochemistry·2025
Same author

Runx2 deletion in hypertrophic chondrocytes impairs osteoclast mediated bone resorption.

Bone·2024
Same author

Spatiotemporal Epigenetic Control of the Histone Gene Chromatin Landscape during the Cell Cycle.

Critical reviews in eukaryotic gene expression·2023
Same author

Corrigendum: Loss of early B cell protein λ5 decreases bone mass and accelerates skeletal aging.

Frontiers in immunology·2023

Related Experiment Video

Updated: Dec 31, 2025

Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments
03:49

Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments

Published on: October 13, 2023

1.6K

Nuclear microenvironments in biological control and cancer.

Sayyed K Zaidi1, Daniel W Young, Amjad Javed

  • 1University of Massachusetts Medical School and UMASS Memorial Cancer Center, Worcester, Massachusetts, USA.

Nature Reviews. Cancer
|May 25, 2007
PubMed
Summary

Nuclear organization of nucleic acids and proteins is crucial for gene regulation and DNA repair. Cancer disrupts these structures, offering new diagnostic and therapeutic targets.

More Related Videos

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
08:20

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

5.9K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

10.1K

Related Experiment Videos

Last Updated: Dec 31, 2025

Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments
03:49

Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments

Published on: October 13, 2023

1.6K
Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
08:20

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

5.9K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

10.1K

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Biology

Background:

  • The nucleus contains specialized microenvironments where nucleic acids and regulatory proteins are organized.
  • This subnuclear organization is essential for integrating physiological signals that control gene expression, DNA replication, and repair.
  • Alterations in nuclear organization are frequently observed in various cancers.

Purpose of the Study:

  • To investigate the role of nuclear compartmentalization in gene regulation and cellular processes.
  • To understand how cancer affects the composition and organization of regulatory complexes within the nucleus.
  • To explore the potential of nuclear organization insights for cancer diagnosis and therapy.

Main Methods:

  • Analysis of subnuclear microenvironments.
  • Characterization of regulatory complex assembly at intranuclear sites.
  • Investigation of temporal and spatial organization of gene expression machinery.

Main Results:

  • Subnuclear compartmentalization of nucleic acids and proteins supports key cellular functions.
  • Cancer is associated with significant changes in nuclear organization and regulatory complex composition.
  • Dysregulation of nuclear organization machinery is a hallmark of tumors.

Conclusions:

  • Nuclear organization plays a critical role in maintaining cellular functions like gene expression and DNA repair.
  • Aberrant nuclear organization in cancer presents opportunities for novel diagnostic and therapeutic strategies.
  • Understanding the spatial and temporal dynamics of nuclear machinery is key to developing new cancer treatments.